The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125970342 12597034 2 F 2002 20160906 20160726 20160914 EXP US-ASTRAZENECA-2016SE77941 ASTRAZENECA 67.00 YR M Y 120.20000 KG 20160914 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125970342 12597034 1 PS FASLODEX FULVESTRANT 1 Intramuscular 21344 INJECTION
125970342 12597034 2 SS TAMOXIFEN TAMOXIFEN 1 Oral N U 0 TABLET
125970342 12597034 3 SS IBRANCE PALBOCICLIB 1 Oral 125 MG, 28 DAYS SUPPLY U U 0 CAPSULE
125970342 12597034 4 C COLACE DOCUSATE SODIUM 1 0 100 MG CAPSULE QD
125970342 12597034 5 C COREG CARVEDILOL 1 0 TABLET
125970342 12597034 6 C ASPIRIN. ASPIRIN 1 325 MG, TABLET DEYALED RELEASE 0
125970342 12597034 7 C FOLIC ACID. FOLIC ACID 1 0 TABLET
125970342 12597034 8 C GLIMEPIRIDE. GLIMEPIRIDE 1 0 TABLET
125970342 12597034 9 C METOPROLOL. METOPROLOL 1 0 TABLET
125970342 12597034 10 C FUROSEMIDE. FUROSEMIDE 1 0 TABLET
125970342 12597034 11 C TRICOR FENOFIBRATE 1 0 TABLET
125970342 12597034 12 C VYTORIN EZETIMIBESIMVASTATIN 1 10 MG - 20 MG 0 TABLET
125970342 12597034 13 C LETROZOLE. LETROZOLE 1 0
125970342 12597034 14 C SIMVASTATIN. SIMVASTATIN 1 0 TABLET
125970342 12597034 15 C LANTUS INSULIN GLARGINE 1 Subcutaneous 100 IU/ML 0
125970342 12597034 16 C METFORMIN METFORMIN HYDROCHLORIDE 1 0 TABLET
125970342 12597034 17 C PLAVIX CLOPIDOGREL BISULFATE 1 0 TABLET
125970342 12597034 18 C QUINAPRIL. QUINAPRIL 1 0
125970342 12597034 19 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125970342 12597034 1 Breast cancer male
125970342 12597034 2 Breast cancer male
125970342 12597034 3 Breast cancer male

Outcome of event

Event ID CASEID OUTC COD
125970342 12597034 OT
125970342 12597034 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125970342 12597034 Acute coronary syndrome
125970342 12597034 Amnesia
125970342 12597034 Confusional state
125970342 12597034 Cough
125970342 12597034 Deep vein thrombosis
125970342 12597034 Dyspnoea
125970342 12597034 Fatigue
125970342 12597034 Hallucination
125970342 12597034 Hot flush
125970342 12597034 Malignant neoplasm progression
125970342 12597034 Metastases to central nervous system
125970342 12597034 Metastases to lung
125970342 12597034 Nephrogenic anaemia
125970342 12597034 Nephropathy
125970342 12597034 Neuropathy peripheral
125970342 12597034 Oedema peripheral
125970342 12597034 Skin discolouration

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125970342 12597034 1 2012 0
125970342 12597034 2 2002 2002 0